Detalles de la búsqueda
1.
Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
BMC Public Health
; 21(1): 597, 2021 03 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-33771150
2.
A systematic mixed studies review of health behaviour change interventions in colorectal cancer survivors.
J Adv Nurs
; 76(8): 1936-1948, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32281687
3.
The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control.
Hum Mol Genet
; 23(8): 1975-89, 2014 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24271015
4.
Provincial variation in colorectal cancer screening adherence in Canada; evidence from the Canadian Partnership for Tomorrow's Health.
Front Oncol
; 13: 1113907, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37397357
5.
British Columbia's COVID-19 surveys on population experiences, action, and knowledge (SPEAK): methods and key findings from two large cross-sectional online surveys.
Can J Public Health
; 114(1): 44-61, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36459366
6.
Adverse events related to bystander naloxone administration in cases of suspected opioid overdose in British Columbia: An observational study.
PLoS One
; 16(10): e0259126, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714854
7.
Accessing Take-Home Naloxone in British Columbia and the role of community pharmacies: Results from the analysis of administrative data.
PLoS One
; 15(9): e0238618, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32915834
8.
Correlates of take-home naloxone kit possession among people who use drugs in British Columbia: A cross-sectional analysis.
Drug Alcohol Depend
; 205: 107609, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31654839
9.
Impact on immigrant screening adherence with introduction of a population-based colon screening program in Ontario, Canada.
Cancer Med
; 8(4): 1826-1834, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30791219
Resultados
1 -
9
de 9
1
Próxima >
>>